Blood Donation Could Improve Insulin Sensitivity

NCT ID: NCT05791968

Last Updated: 2025-02-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

89 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-15

Study Completion Date

2024-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Studies in the literature suggest that people with obesity have an excess of stored iron. There is possibly an inverse relationship between ferritin levels and the actions of insulin on glycemic control. The reduction of stored iron by simply donating blood could result in improvements in glycemic control in people with obesity and prediabetes. We propose, to reduce ferritin levels through a standard donation of a unit of whole blood, and to measure if it positively affects glycemic control.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Individuals with pre-diabetes and abdominal obesity will be randomized to either a donation group (DON) or a control group (CONT) in a double-blind fashion (RCT).

Insulin sensitivity during an oral glucose tolerance test (OGTT) and isotopically measured rate of appearance of endogenous and exogenous glucose will be measured on 2 occasions.

1. Two weeks prior to DON/CONT
2. Two weeks after to DON/CONT

Indexes of the bodily iron stores will be measured after DON/CONT to evaluate if the primary treatment was effective.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ferritin Insulin Sensitivity Blood Donation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized, control group, trial (RCT)
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
participants in the control group will have the standard blood bank donation venipuncture, but no blood will be withdrawn (sham donation).

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

DONATION GROUP

Participants will be measured before and after a standard blood bank donation (450 mL of whole blood withdrawal)

Group Type ACTIVE_COMPARATOR

Whole blood standard donation

Intervention Type PROCEDURE

Effects of a standard whole blood donation on iron stores and insulin sensitivity.

CONTROL GROUP

Participants will be measured before and after a sham blood donation (0 mL of whole blood withdrawal)

Group Type SHAM_COMPARATOR

Whole blood standard donation

Intervention Type PROCEDURE

Effects of a standard whole blood donation on iron stores and insulin sensitivity.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Whole blood standard donation

Effects of a standard whole blood donation on iron stores and insulin sensitivity.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* have not donated in the last 3 months
* IMC\>25
* fasting blood glucose 100-125 mg/dL
* glycosylated hemoglobin levels between 5.7-6.4%

Exclusion Criteria

* to not meet donor bank requirements
* insulin treatment for diabetes
* anemia
* hereditary hemochromatosis
* heart disease
* familial hypertriglyceridemia or hypobetalipoproteinemia
* any disease that requires medication that interferes with iron or glucose metabolism
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

SESCAM Centro Regional de Transfusión Toledo-Guadalajara.

UNKNOWN

Sponsor Role collaborator

University of Castilla-La Mancha

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ricardo Mora

Director of Exercise Physiology Laboratory

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Castilla-La Mancha (Exercise Physiology Lab)

Toledo, Toledo, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

References

Explore related publications, articles, or registry entries linked to this study.

Moreno-Navarrete, J. M., M. Moreno, J. Puig, G. Blasco, F. Ortega, G. Xifra, W. Ricart and J. M. Fernandez-Real (2017).

Reference Type BACKGROUND

Van Pelt, D. W., S. A. Newsom, S. Schenk and J. F. Horowitz (2015).

Reference Type BACKGROUND

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CEIC-CHUT-969

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Glucose, Brain and Microbiota
NCT03889132 ACTIVE_NOT_RECRUITING